小鼠子宫内膜干细胞的初步研究
详细信息    本馆镜像全文|  推荐本文 |  |   获取CNKI官网全文
摘要
第一部分小鼠子宫标记滞留细胞的检测
     目的:研究小鼠子宫内标记滞留细胞的存在及其分布特点。
     方法:选择出生三天的雌性昆明白小乳鼠,实验组乳鼠皮下注射BrdU50ug/g,对照组皮下注射生理盐水100ul,每天2次,共注射3d。于最后一次注射后2h、1w、2w、4w和8w处死并取子宫固定,石蜡包埋用于免疫组化检测,每个时间段5只乳鼠。
     结果:实验组标记后2h,小鼠腺体和基质中标记滞留细胞(LRCs)表达最高,分别为45.1%和57.4%,随着时间的增加,LRCs逐渐降低,到第8w在腺体中仅有极少量细胞表达,而基质细胞约有1.5%的LRCs,主要位于血管周围和内膜基层连接处。不同时相腺体和基质细胞中LRCs差异具有显著性(P<0.05)。
     结论:昆明白小鼠子宫内LRCs主要位于血管周围和内膜基层连接处等,这些LRCs可能为子宫内膜干细胞。
     第二部分体外培养小鼠子宫内膜形成克隆能力的检测
     目的:通过体外培养检测小鼠子宫内膜细胞克隆能力。
     方法:取出生3d的昆明白雌性小鼠,将其子宫剪碎后用0.125%胰酶消化,计数活细胞,按300个/cm2的密度接种到培养瓶中,培养12d左右。观察细胞及克隆生长特点,并测量细胞克隆大小和计算克隆形成率。同时取成年小鼠子宫培养作为对照。通过组织来源、细胞生长形态、细胞增殖能力以及角蛋白和波型蛋白免疫组化等进行鉴定,并用免疫荧光法检测腺体克隆Ki-67增殖指数。
     结果:根据细胞组织来源分有腺体和基质两种克隆,根据细胞克隆大小和生长特点,分大克隆和小克隆两种类型。腺体大克隆和小克隆的大小分别为3.64±1.1和0.53±0.24mm,克隆形成率分别为0.051±0.013%和0.11±0.07%;基质大克隆和小克隆的直径大小分别为2.82±0.5和0.41±0.13mm,克隆形成率分别为0.008±0.001%和0.43±0.03%。四种克隆的克隆形成率均具有显著性差异(P<0.05),腺体和基质大克隆直径大小,腺体和基质小克隆直径大小分别两两比较,差异不均具有显著性(P>0.05),而腺体大小克隆大小比较,基质大小克隆分别两两比较,差异具有均显著性(P<0.05)。成年小鼠子宫有限稀释法原代培养无细胞克隆生长。腺体大克隆Ki-67增殖指数高于腺体小克隆(P<0.05)。
     结论:子宫内膜细胞在体外培养中,可以形成单细胞克隆,腺体和基质细胞均可形成大克隆和小克隆。腺体大克隆增殖能力高于小克隆。
     第三部分EGF和17β-雌二醇对细胞克隆生长的影响
     目的:研究EGF和17β-雌二醇对子宫内膜细胞克隆生长的影响。
     方法:在培养基中分别加入10ng/ml的EGF和5×10-8 mol/L的17β-雌二醇,按照第二部分方法对小鼠子宫进行原代培养,观察细胞形态,测量克隆大小并计算细胞克隆形成率,同时用无特殊添加成分的培养基培养作为对照。
     结果:与对照组比较,EGF组四种克隆形成率且克隆直径均值略高,但是差异不具有显著性(均P>0.05)。17β-雌二醇组两种小克隆克隆形成率均值略高,而两种大克隆克隆形成率较低,与对照组分别比较差异不具有显著性(均P>0.05)。17β-雌二醇组腺体大克隆大于对照组,差异具有显著性(P<0.05), 17β-雌二醇组与EGF组比较,细胞克隆形成率和大小差异均不具有显著性(P>0.05)。
     结论:添加EGF和17β-雌二醇对小鼠子宫在体外培养时,并不能增加其克隆形成率,雌激素在体外有促进腺体克隆细胞分化的作用。
     第四部分小鼠间充质干细胞向子宫内膜方向分化的实验研究
     目的:探索小鼠骨髓间充质干细胞向子宫内膜的迁移和分化
     方法: 1.体外原代培养雄性小鼠骨髓间充质干细胞,并在体外用BrdU体外标记,用CD34和CD29抗体进行免疫组化鉴定,用BrdU抗体检测其标记阳性率。
     2.骨髓移植模型:雌性小鼠放疗后,从鼠尾静脉注射移植间充质干细胞,作为放疗后移植组;同时设放疗对照和正常对照组。每组8只小鼠。
     3.观察小鼠的一般情况,在小鼠濒死前或者生存>60d后,处死小鼠,取其子宫一侧固定石蜡包埋,用于BrdU免疫组化;另一侧子宫提取DNA,用于PCR检测Sry基因表达。
     结果: 1.间充质干细胞呈梭形或多角形,经免疫组化鉴定CD29(+)和CD34(-),符合间充质干细胞特性。Brdu标记阳性率约为80%。
     2.骨髓移植模型:放疗对照组在放疗后14d小鼠死亡7/8只;移植组移植后4只存活时间<20d,2只存活时间>30d,2只存活时间>60d。放疗对照组、正常对照组和移植组早期死亡小鼠子宫Brdu检测为阴性。移植组短期存活和长期存活的小鼠,Brdu阳性主要表达在子宫腺体和基质之间的毛细血管内皮细胞及少量基质细胞核内。正常对照组和放疗组小鼠子宫SRY基因检测为阴性。移植组早期死亡、短期存活和长期存活的小鼠子宫SRY基因表达均为阳性。
     结论:小鼠间充质干细胞可以迁移到子宫,并有可能成为子宫内膜修复的细胞来源。
Part I The existence of endometrial stem cell in mouse uterus
     Objective:
     To study the existence of endometrial stem cell and its distribution in mouse uterus.
     Methods:
     Selected female Kunming white mice after born three days, subcutaneous injected BrdU50ug/g in experiment group and 0.9%NS in control group twice daily andtotally injected 3 d. Put mice death after injected 2h、1w、2w、4w和8w, fixed the uterus forimmunohistochemistry and pathology, 5 mice for each phase.
     Results:
     The expression of LRCs in stroma and gland cells after 2h were 45.1% and 57.4%respectively and which were gradually degraded. Only few LRCs in the gland bottom in 8wand 1.5% LRCs in stroma cells mainly located around the blood vessel andendometrial-myometrial junction. LRCs in different phases of stroma and gland cells weresignificance(P<0.05).
     Conclusions:
     There were endometrial stem cells in the uterus of Kunming white mice and mainly locatedaround the blood vessel and endometrial-myometrial junction.
     Part II The cloning efficiency of mouse endometrium in vitro primaryculture
     Objective:
     To study the cloning efficiency of mouse endometrium in vitro primary culture by limiteddilution technology.
     Methods:
     Selected the female kuming mice after born 3 days, sheared and digested the uterus by0.125% pancreatic enzyme, counting the living cells and inoculating them to culture flask.Observed the characteristics of cell clones during 12days and measured the sizes of clonesand calculated the rate of cloning efficiency. At the same time, cultured the uterus cells ofadult female mice as control. Identification the category of the cells by keratin and vimentinby immunohistochemistry and appearance of the cells、the origin of tissue. Detected theproliferation index of Ki-67 in gland clones by immunofluorescence.
     Results:
     There were stroma and gland clones divided by the cell origin, large and little clonesdivided by size and growth characteristics. The sizes of large and little gland clones wererespectively 3.64±1.1 and 0.53±0.24mm, the cloning efficiency was respectively 0.051%±0.013 and 0.11±0.07%;The sizes of large and little stroma clones was respectively 2.82±0.5 and 0.41±0.13 mm, the cloning efficiency was respectively 0.008±0.001% and0.43±0.03%. There was no cell growth in the adult uterus by limited dilution technology.The difference of the cloning efficiency rates of four kids of clones were all significant(P<0.05).Compared the sizes of two kinds of large clones or the two kinds of little clones,the differences were not significan(t P>0.05), The PI of Ki-67 was higher in the nucleus oflarge clones.
     Conclusion:
     The endometrium cells can form monocell clones in vitro primary culture which includedlarge and little clones. The proliferation efficiency of the large gland clone was higher.
     Part III The effects of EGF and 17β-Estradiol to the growth of cellclones
     Objective:
     To study the effects of EGF and 17β-Estradiol on the growth of cell clones.
     Methods:
     Added 10ng/ml EGF or 5×10-8 mol/L 17β-Estradiol into the medium, cultured the cell asthe methods of the part II and observed the cell appearance、measured the sizes of clonesand calculated the rate of cloning efficiency.
     Results:
     The rates of cloning efficiency in the EGF groups were higher than the control group, thedifference were not significant(P>0.05). The cloning efficiency rates of little clones in17β-Estradiol groups were higher than the control group, while the cloning efficiency ratesof large clones were lower, the difference were not significan(t P>0.05). The large clones in17β-Estradiol groups were larger than the control group and the difference were significant(P<0.05).The difference of the cloning efficiency rates and the sizes of the clones werenot significance in the EGF groups and 17β-Estradiol groups(P>0.05).
     Conclutions:
     when added 10ng/ml EGF or 5×10-8 mol/L 17β-Estradiol into the medium, the rates ofcloning efficiency were not higher. 17β-Estradiol could promote the differentiation of thegland clones.
     Part IV The experiment research of mesenchymal stem cellsdifferentiation to the endometrium
     Objective:
     To study the immigration and differentiation of mesenchymal stem cells to endometrium.
     Methods:
     1. Cultured the male MSCs and labeling the Brdu in vitro, then identified by CD34 andCD29; the positive rate of Brdu was examined by immunohistochemistry.
     2. After radiotherapy, the MSCs were injected through the tail vein of female mouse astransplantation group. The other groups were radiotherapy group and normal control group.Each groups had 8 mice.
     3. Observe the general condition of mice and put them death before died or living longer>60d, taken one uterus for immunohistochemistry and pathology the others for PCR and.
     Results:
     1.The MSCs was CD29(+)and CD34(-)and the Brdu positive rate was roughly 80%.
     2. 7/8 mice died in 14 days; 4 mice lived <20d; 2 mice survived longer >30d; 2 mice livedlonger >60d in the radiotherapy group. The Brdu was negative in radiotherapy、normalcontrol groups and early died mice in experimental group. In the long-living andshort-living mice of transplantation group, Brdu expressed on the endothelial cells of bloodcapillary and few stroma cells. The SRY gene was negative in radiotherapy、normal controlgroups and early died mice in experimental group, but it was positive in the uterus oflong-living and short-living mice.
     Conclusion:
     The mouse MSCs can immgrate to the uterus and maybe one of the origin ofendometrium.
引文
1.朱桂金,靳镭,章汉旺等. 2014例辅助生殖手术的临床分析.华中科技大学学报(医学版); 2004,33(1): 65-67.
    2. Gunby J, Daya S. Assisted reproductive technologies (ART) in Canada: 2002 resultsfrom the Canadian ART Register. Fertil Steril. 2006 Nov;86(5):1356-64.
    3.中华人民共和国卫生部令第14号,《人类辅助生殖技术管理办法》,自2001年8月1日起施行.
    4. Schenker JG. Assisted reproduction practice in Europe: legal and ethical aspects.HumReprod Update. 1997 Mar-Apr;3(2):173-84.
    5. Brannstrom M, Wranning CA. Uterus transplantation: where do we stand today andwhere should we go? Expert Opin Biol Ther. 2007 Apr;7(4):427-9.
    6. Prianishnikov VA. On the concept of stem cell and a model of functional-morphologicalstructure of the endometrium. Contraception. 1978 Sep;18(3):213-23.
    7. Chan RW, Schwab KE, Gargett CE.Clonogenicity of human endometrial epithelial andstromal cells.Biol Reprod. 2004 Jun;70(6):1738-50. Epub 2004 Feb 6.
    8. Tanaka M, Kyo S, Kanaya T et al. Evidence of the composition of human endometrialepithelial glands and mosaic pattern of clonal distribution in luminal epithelium.Am JPathol. 2003 Jul; 163(1):295-301.
    9. Chan RW, Gargett CE. Identification of label-retaining cells in mouse endometrium.Stem Cells. 2006 Jun;24(6):1529-38. Epub 2006 Feb 2.
    10.习佳飞,王韫芳,裴雪涛.成体干细胞及其在再生医学中的应用.生命科学.2006Aug;18(4):238-332.Moraleda JM, Blanquer M, Bleda P. Adult stem cell therapy:dream or reality?Transpl Immunol. 2006 Dec;17(1):74-7. Epub 2006 Oct 16.
    12.赵春华.廖联明.对成体干细胞可塑性的新认识及其在再生医学中的意义中华血液病学杂志.2003,24(2);57-58.
    13. Kashofer K, Bonnet D. Gene therapy progress and prospects: stem cell plasticity.GeneTher. 2005 Aug;12(16):1229-34. Review.
    14. Yoon J, Shim WJ, Ro YM, Lim DS. Transdifferentiation of mesenchymal stem cellsinto cardiomyocytes by direct cell-to-cell contact with neonatal cardiomyocyte but notadult cardiomyocytes. Ann Hematol. 2005 Oct;84(11):715-21. Epub 2005 Aug 12.
    15. Wislet-Gendebien S, Hans G, Leprince P. Plasticity of cultured mesenchymal stem cells:switch from nestin-positive to excitable neuron-like phenotype. Stem Cells. 2005 Mar;23 (3): 392-402.
    16. Jiang Y, Jahagirdar BN, Reinhardt RL et al. Pluripotency of mesenchymal stem cellsderived from adult marrow. Nature. 2002 Jul 4; 418(6893):41-9. Epub 2002 Jun 20.
    17. Gilbert H. Label-retaining epithelial cells in mouse mammary gland divideasymmetrically and retain their template DNA strands. Development 132 (4):681-687.
    18. Cairns J.Cancer and the immortal strand hypothesis.Genetics. 2006 Nov; 174(3):1069-72.
    19. Park Y, Gerson SL.DNA repair defects in stem cell function and aging. Annu Rev Med.2005; 56: 495-508.
    20. Potten CS, Owen G, Booth D.Intestinal stem cells protect their genome by selectivesegregation of template DNA strands.J Cell Sci. 2002 Jun 1;115(Pt 11):2381-8.
    21. Grandel H, Kaslin J, Ganz Jet al. Neural stem cells and neurogenesis in the adultzebrafish brain: origin, proliferation dynamics, migration and cell fate.Dev Biol. 2006Jul 1;295(1):263-77. Epub 2006 Apr 4.
    22. Kim SJ, Cheung S, Hellerstein MK. Isolation of nuclei from label-retaining cells andmeasurement of their turnover rates in rat colon. Am J Physiol Cell Physiol. 2004Jun;286(6):C1464-73. Epub 2004 Feb.
    23.Martin L, Finn CA, Trinder G. DNA synthesis in the endometrium of progesteronetreated mice. J Endocrinol. 1973 Feb;56(2):303-7.
    24. Lipschutz JH, Fukami H, Yamamoto M et al. Clonality of urogenital organs asdetermined by analysis of chimeric mice. Cells Tissues Organs. 1999; 165(2):57-66
    25. Mutter GL, Lin MC, Fitzgerald JT et al. Changes in endometrial PTEN expressionthroughout the human menstrual cycle.J Clin Endocrinol Metab. 2000 Jun; 85 (6):2334-8.
    1. Prianishnikov VA. On the concept of stem cell and a model of functionalmorphologicalstructure of the endometrium. Contraception. 1978 Sep;18(3):213-23.
    2. Lipschutz JH, Fukami H, Yamamoto M et al. Clonality of urogenital organs asdetermined by analysis of chimeric mice. Cells Tissues Organs. 1999; 165(2):57-66.
    3. Chan RW, Schwab KE, Gargett CE.Clonogenicity of human endometrial epithelial andstromal cells.Biol Reprod. 2004 Jun;70(6):1738-50. Epub 2004 Feb 6.
    4. Chan RW, Gargett CE. Identification of label-retaining cells in mouseendometrium.Stem Cells. 2006 Jun;24(6):1529-38. Epub 2006 Feb 2.
    5. Gratzner HG.Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: A new reagentfor detection of DNA replication.Science. 1982 Oct 29;218(4571):474-5.
    6. Martin L, Finn CA, Trinder G. DNA synthesis in the endometrium of progesteronetreatedmice. J Endocrinol. 1973 Feb;56(2):303-7.
    7. Lipschutz JH, Fukami H, Yamamoto M et al. Clonality of urogenital organs asdetermined by analysis of chimeric mice. Cells Tissues Organs. 1999; 165(2):57-66.
    8. Mutter GL, Lin MC, Fitzgerald JT et al. Changes in endometrial PTEN expressionthroughout the human menstrual cycle.J Clin Endocrinol Metab. 2000 Jun;85(6):2334-8.
    9. Vainio S, Heikkil M, Kispert A, Chin N, McMahon AP. Female development inmammals is regulated by Wnt4 signaling. Nature 1999; 397: 405-9.
    10.裴雪涛,刘大庆.干细胞:组织器官重建的理想种子细胞.中国修复重建外科杂志.2006;20(4):344-348.
    11. Gargett CE.Identification and characterisation of human endometrial stem/progenitorcells.Aust N Z J Obstet Gynaecol. 2006 Jun;46(3):250-3.
    12. Gilbert H. Label-retaining epithelial cells in mouse mammary gland divideasymmetrically and retain their template DNA strands. Development 132 (4):681-687.
    13. Chan RW, Gargett CE. Identification of label-retaining cells in mouse endometrium.Stem Cells. 2006 Jun;24(6):1529-38. Epub 2006 Feb 2.
    14. Cairns J.Cancer and the immortal strand hypothesis.Genetics. 2006 Nov; 174(3):1069-72.
    15. Lin P, Allison DC.Measurement of DNA comtent and of tritated thymidine andbromodeoxyuridine incorporation by the same cells .J histochem Cytochem. 1993,Sep;41(9):1435-9.
    16. Cho NH, Park YK, Kim YT et al.Fertil Steril. 2004 Feb;81(2):403-7. Lifetimeexpression of stem cell markers in the uterine endometrium.
    1. Tanaka M, Kyo S, Kanaya T et al. Evidence of the composition of human endometrialepithelial glands and mosaic pattern of clonal distribution in luminal epithelium.Am JPathol.2003 Jul;163(1):295-301.
    2. Mutter GL,Lin MC,Fitzgerald JT et al.Changes in endometrial PTEN expressionthroughout the human menstrual cycle.J Clin Endocrinol Metab.2000 Jun;85(6):2334-8.
    3. Chan RW,Schwab KE,Gargett CE.Clonogenicity of human endometrial epithelialand stromal cells.Biol Reprod.2004 Jun;70(6):1738-50.Epub 2004 Feb 6.
    4.王从朱,王红.促甲状腺激素单克隆抗体的制备和应用.放射免疫学杂志.2005,18(02):146-147.
    5.娄华,申爱荣,杨淑玲等.p27~(kip1)和ki-67在子宫内膜异位症中的表达与意义.中国妇产科临床杂志.2006,7(03):196-198.
    6.胡琳莉,王昕荣,朱桂金等.Wnt-4在雌性小鼠苗勒管中的表达及意义.生殖与避孕.2007,27(4)
    7. Chan RW,Schwab KE,Gargett CE.Clonogenicity of human endometrial epithelialand stromal cells..Biol Reprod.2004 Jun;70(6):1738-50.Epub 2004 Feb 6.
    8.钱坤,陈红,魏玉兰等.离体异位子宫内膜细胞ki-67、钙粘素-E的表达及自发凋亡测定.生殖与避孕.2004,24 (04):210-214.
    9.曾卫,封志纯.人子宫内膜细胞的体外培养技术及鉴定.中国现代医学杂志.1999,9(06):11-13.
    10. Chan RW, Gargett CE. Identification of label-retaining cells in mouse endometrium.Stem Cells.2006 Jun;24(6):1529-38.Epub 2006 Feb 2.
    11. Martin L, Finn CA,Trinder G.DNA synthesis in the endometrium of progesteronetreatedmice.J Endocrinol.1973 Feb;56(2):303-7.
    12. Schwab KE,Chan RW, Gargett CE.Putative stem cell activity of human endometrialepithelial and stromal cells during the menstrual cycle.Fertil Steril.2005 Oct;84 Suppl2:1124-30.
    13. Tanaka M, Kyo S, Kanaya T et al. Evidence of the composition of human endometrialepithelial glands and mosaic pattern of clonal distribution in luminal epithelium.Am JPathol.2003 Jul;163(1):295-301.
    14. Mutter GL,Lin MC,Fitzgerald JT et al.Changes in endometrial PTEN expressionthroughout the human menstrual cycle.J Clin Endocrinol Metab.2000 Jun;85(6):2334-8.
    15. Gargett CE.Identification and characterisation of human endometrial stem/progenitorcells.Aust N Z J Obstet Gynaecol.2006 Jun;46(3):250-3.
    16.吕威力,邢雪松,董玉兰等.成纤维细胞生长因子促内皮细胞增生作用及其机制.中华创伤杂志.2004,20(06):363-366.
    1.廖小金.表皮生长因子结构和生物学效应.海峡药学.2006,16(5):278-280.
    2.郝晶,高英茂,李盛芳等.着床期小鼠子宫内膜中EGF及其受体转录和表达状况的研究.中国组织化学与细胞化学杂志.2001,(03);159-161.
    3. Xu RH,Peck RM,Li DS et al.Basic FGF and suppression of BMP signalingsustain undifferentiated proliferation of human ES cells.Nat Methods. 2005 Mar;2(3):185-90.Epub 2005 Feb 17.
    4.桂耀庭,王介东,王弘毅.表皮生长因子受体在人子宫内膜、蜕膜和绒毛的免疫组化定位.生殖医学杂志,1996,16(2):154-156.
    5.石运芝,刘凯,李伯勤等.着床窗口小鼠子宫内膜上皮细胞原代培养及形态学观察.泰山医学院学报.2004,25(6):570-572.
    6.段发亮,马廉亭,秦尚振.EGF对神经干细胞迁移的影响中国临床神经外科杂志.2005,10(3):201-203.
    7. Chan RW,Schwab KE,Gargett CE.Clonogenicity of human endometrial epithelialand stromal cells.Biol Reprod.2004 Jun;70(6):1738-50.Epub 2004 Feb 6.
    8.荣顺兴.金泰廙.雌激素受体的研究进展.职业卫生与应急救援.2005,(01):56-58.
    9.胡琳莉,王昕荣,朱桂金等.ER在雌性小鼠苗勒管中的表达及意义.待投稿
    10. Couse JF,Korach KS.Estrogen receptor null mouse:what have we learned and wherewill they lead us ?Endocr Rev,1999;20(3):358-417.
    11. Chan RW,Gargett CE.Identification of label-retaining cells in mouse endometrium.Stem Cells.2006 Jun;24(6):1529-38.Epub 2006 Feb 2.
    12. Handa RJ,Price RH,WlisonME.Steroid hormonereceptorsi the developingbrain.BiomedRev,1997;(17):51~64.
    13.郑小璞,马爱群,韩克等.雌激素对急性心肌梗死前后去卵巢大鼠干细胞及心功能的影响.细胞与分子免疫学杂志.2006,22(3):350-352.
    14. Deasy BM,Lu A,Tebbets JC et al.A role for cell sex in stem cell-mediated skeletalmuscle regeneration:female cells have higher muscle regeneration efficiency.J CellBiol.2007 Apr 9;177(1):73-86.
    1.谌卫,姚真真,冯伟华等.成体干细胞的可塑性.生命的化学. 2004, 24(04):296-298.
    2. Jiang Y, Jahagirdar BN, Reinhardt RL et al. Pluripotency of mesenchymal stem cellsderived from adult marrow. Nature. 2002 Jul 4; 418(6893):41-9. Epub 2002 Jun 20.
    3.张伟,尤胜国.骨髓间充质干细胞免疫学特性的研究进展.细胞与分子免疫学杂志, 2005, 21(06):801-802.
    4. Taylor HS.Endometrial cells derived from donor stem cells in bone marrow transplantrecipients. JAMA. 2004 Jul 7;292(1):81-5.
    5.肖承佐,章乐虹,张昊等.成体小鼠骨髓间充质干细胞的培养和纯化.现代临床医学生物工程学杂志.2005,11(6):477-480.
    6.黄孝文,肖红俊,汪吉宝等.用BrdU标记技术观察大鼠内淋巴囊的S期细胞.中国组织化学与细胞化学杂志.2002,11(4):403-404.
    7.许贞书,刘拥军,吕璐璐等.小鼠骨髓间充质干细胞生物学特性和体外诱导分化.基础医学与临床.2005,25(2):128-133.
    8.王韫芳,南雪,尉承泽等.丙烯醇致肝损伤微环境定向诱导骨髓干细胞向肝细胞分化.中华肝脏病杂志.2005,13(4):274-277.
    9.项莺松,杨如俊,孟祥顺等.小鼠骨髓程序移植的实验研究.中华血液学杂志.1998,19(12):634-637.
    10. Gubbay J, Collignon J,Koopman P,et al.A gene mapping to sec-determining region ofthe mouse Y chromosome is a member of a novel family of embryonically expressedgenes.Nature,1990,346(6281):245-250.
    11. Hanada K, Dennis JE, Caplan AI.Stimulatory effects of basic fibroblast growth factorand bone morphogenetic protein-2 on osteogenic differentiation of rat bone marrowderivedmesenchymal stem cells. J Bone Miner Res. 1997 Oct;12(10):1606-14.
    12. Krampera M, Marconi S, Pasini A et al.Induction of neural-like differentiation inhuman mesenchymal stem cells derived from bone marrow, fat, spleen and thymus.Bone. 2007 Feb;40(2):382-90. Epub 2006 Oct 16.
    13. Pittenger M, Vanguri P, Simonetti D et al.Adult mesenchymal stem cells: potential formuscle and tendon regeneration and use in gene therapy.J Musculoskelet NeuronalInteract. 2002 Jun;2(4):309-20.
    14. Li A, Zhang Q, Jiang J, Yuan G et al.Co-transplantation of bone marrow stromal cellstransduced with IL-7 gene enhances immune reconstitution after allogeneic bone marrowtransplantation in mice.Gene Ther. 2006Aug;13(15):1178-87. Epub 2006Apr 6.
    15. Kashofer K, Bonnet D. Gene therapy progress and prospects: stem cell plasticity.GeneTher. 2005 Aug;12(16):1229-34.
    16. Castro R F, Jackson K A, Goodell M A, et al. Failure of bone marrow cells totransdifferentiate into neural cells in vivo. Science, 2002, 297(5585): 1299.
    17. Kumar BM, Jin HF, Kim JG et al.Differential gene expression patterns in porcinenuclear transfer embryos reconstructed with fetal fibroblasts and mesenchymal stemcells.Dev Dyn. 2007 Feb;236(2):435-46.
    18. Willenbring H, Bailey AS, Foster M et al.Myelomonocytic cells are sufficient fortherapeutic cell fusion in liver.Nat Med. 2004 Jul;10(7):744-8. Epub 2004 Jun 13.
    19. Wang X, Willenbring H, Akkari Y et al. Cell fusion is the principal source ofbone-marrow-derived hepatocytes.Nature. 2003 Apr 24;422(6934):897-901. Epub 2003Mar 30.
    20. Rizvi AZ, Swain JR, Davies PS et al.Bone marrow-derived cells fuse with normal andtransformed intestinal stem cells.Proc Natl Acad Sci U S A. 2006 Apr 18;103(16):6321-5. Epub 2006 Apr 10.
    21.赵春华.廖联明.对成体干细胞可塑性的新认识及其在再生医学中的意义中华血液病学杂志.2003,24(2);57-58.
    22. Jiang Y, Jahagirdar BN, Reinhardt RL et al. Pluripotency of mesenchymal stem cellsderived from adult marrow. Nature. 2002 Jul 4; 418(6893):41-9. Epub 2002 Jun 20.
    23. Verfaillie CM. Multipotent adult progenitor cells: an update. Novartis Found Symp.2005;265:55-61; discussion 61-5, 92-7.
    24. Taylor HS.Endometrial cells derived from donor stem cells in bone marrow transplantrecipients. JAMA. 2004 Jul 7;292(1):81-5.
    25. Burns CE, Zon LI.Portrait of a stem cell.Dev Cell. 2002 Nov;3(5):612-3.
    1. Prianishnikov VA. On the concept of stem cell and a model of functionalmorphologicalstructure of the endometrium. Contraception. 1978 Sep;18(3):213-23.
    2. Taylor HS.Endometrial cells derived from donor stem cells in bone marrow transplantrecipients. JAMA. 2004 Jul 7;292(1):81-5.
    3. Chan RW, Gargett CE. Identification of label-retaining cells in mouse endometrium.Stem Cells. 2006 Jun;24(6):1529-38. Epub 2006 Feb 2.
    4. Chan RW, Schwab KE, Gargett CE.Clonogenicity of human endometrial epithelial andstromal cells.Biol Reprod. 2004 Jun;70(6):1738-50. Epub 2004 Feb 6.
    5. Cho NH, Park YK, Kim YT et al.Fertil Steril. 2004 Feb;81(2):403-7. Lifetimeexpression of stem cell markers in the uterine endometrium.
    6.赵春华.廖联明.对成体干细胞可塑性的新认识及其在再生医学中的意义中华血液病学杂志.2003,24(2);57-58.
    7. Taylor HS.Endometrial cells derived from donor stem cells in bone marrow transplantrecipients. JAMA. 2004 Jul 7;292(1):81-5.
    8. Chan RW, Schwab KE, Gargett CE. Clonogenicity of human endometrial epithelial andstromal cells.Biol Reprod. 2004 Jun; 70(6):1738-50. Epub 2004 Feb 6.
    9. Schwab KE,Chan RW, Gargett CE. Putative stem cell activity of human endometrialepithelial and stromal cells during the menstrual cycle. Fertil Steril. 2005 Oct;84 Suppl2:1124-30.
    10. Tanaka M, Kyo S, Kanaya T et al. Evidence of the monoclonal composition of humanendometrial epithelial glands and mosaic pattern of clonal distribution in luminalepithelium.Am J Pathol. 2003 Jul;163(1):295-301.
    11. Chan RW, Gargett CE. Identification of label-retaining cells in mouse endometrium.Stem Cells. 2006 Jun;24(6):1529-38. Epub 2006 Feb 2.
    1. Gratzner HG. Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: A new reagentfor detection of DNA replication.Science. 1982 Oct 29;218(4571):474-5.
    2. Lin P, Allison DC. Measurement of DNA content and of tritated thymidine andbromodeoxyuridine incorporation by the same cells .J histochem Cytochem. 1993,Sep;41(9):1435-9.
    3. Jensen PO, Mortensen BT, Christensen IJ et al. Immediate bromodeoxyuridine labellingof unseparated human bone marrow cells ex vivo is superior to labelling after routinelaboratory processing. Cell Prolif. 1998 Feb;31(1):1-7.
    4. Buchsbaum DJ, Khazaeli MB, Davis MA et al. Sensitization of radiolabeledmonoclonal antibody therapy using bromodeoxyuridine. Cancer. 1994 Feb 1;73(3Suppl):999-1005.
    5. Chandra P, Mildner B. Molecular mechanism of action of diamidinephenylindole(DAPH) III. Physico-chemical binding of DAPI and its derivatives to DNA andpolydeoxynucleotides, and its consequences on the template activity of nucleic acids.Cell Mol Biol Incl Cyto Enzymol. 1979;25(6):429-33.
    6. Coleman AW, Goff LJ. Applications of fluorochromes to pollen biology. I. Mithramycinand 4',6-diamidino-2-phenylindole (DAPI) as vital stains and for quantitation of nuclearDNA.Stain Technol. 1985 May;60(3):145-54.
    7. Radford IR, Martin RF. The estimation of DNA contamination in RNA and enzymepreparations. Anal Biochem. 1982 Nov 15;127(1):116-20.
    8. Ford JW, Welling TH, Stanley JC et al.PKH26 and 125I-PKH95: characterization andefficacy as labels for in vitro and in vivo endothelial cell localization and tracking. JSurg Res. 1996 Apr;62(1):23-8.
    9. Inoue S, Shimomura O, Goda M et al. Fluorescence polarization of green fluorescenceprotein. Proc Natl Acad Sci. 2002 Apr 2; 99(7):4272-7.
    10. Moriyama A, Kii I, Sunabori T, Kurihara S. GFP transgenic mice reveal activecanonical Wnt signal in neonatal brain and in adult liver and spleen.Genesis. 2007Feb;45(2):90-100.
    11.孙文靖,马琳琳,韩菲菲.小鼠HB2GFP真核表达载体的构建与鉴定.国际遗传学杂志。2006;29(1):15-19.
    12.张国俊,赵国强,王华启等.真核绿色荧光蛋白表达载体-pEGF-C3-MAGE-12的构建与表达.中国实用内科杂志2006, 26(6): 425-427.
    13. Cot C, Privat A, Levallois C. Adenoviral-mediated transfection of the Lac-Z gene intorat dissociated embryonic central nervous system cells before and after seeding.Int JDev Neurosci. 1998 Feb;16(1):9-17.
    14. Pawelczyk E, Arbab AS, Pandit S et al. Expression of transferrin receptor and ferritinfollowing ferumoxides-protamine sulfate labeling of cells: implications for cellularmagnetic resonance imaging. NMR Biomed. 2006 Aug;19(5):581-92.
    15. ArbabAS, Yocum GT, Rad AM et al. Labeling of cells with ferumoxides-protamine sulfate complexes does not inhibit function or differentiation capacity ofhematopoietic or mesenchymal stem cells. NMR Biomed. 2005 Dec;18(8):553-9.
    16. Bulte JW, Duncan ID, Frank JA. In vivo magnetic resonance tracking of magneticallylabeled cells after transplantation. J Cereb Blood Flow Metab. 2002 Aug;22(8):899-907.
    17. Pokorna E, Broz L, Vesely P. Y chromosome and vimentin used to trace the fate ofallogeneic keratinocytes delivered to the wound by the recombined human/pig skin.Folia Biol (Praha). 2001;47(4):128-34.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700